Acquires new facility in Mehsana, Gujarat; Expects to start commercial operations from March 2022
Lincoln Pharmaceuticals is planning to launch Cephalosporin products soon. The company has acquired a facility in Mehsana, Gujarat. Investment in Cephalosporin plant of Rs 30 crore includes capacity expansion and modernisation of the facility.The acquisition and further capex will be funded from internal accruals. Company expects commercial operations from March 2022. The plant is expected to contribute sales of around Rs 150 crore in the next 3 years. The plant will cater to all the Cephalosporin products i.e. Tablet, Capsule, Dry syrup and Injectable.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
